Therapeutic significance of laboratory results in rheumatic disease.
Wright
V
V
Dixon
J S
JS
Bird
H A
HA
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D016918:Arthritis, Reactive / Q000503:physiopathology; D001241:Aspirin / Q000627:therapeutic use; D001809:Blood Viscosity; D002097:C-Reactive Protein / Q000097:blood; D002216:Captopril / Q000627:therapeutic use; D002570:Ceruloplasmin / Q000097:blood; D002994:Clofibrate / Q000031:analogs & derivatives / Q000627:therapeutic use; D005787:Gene Frequency; D006052:Gold Sodium Thiomalate / Q000627:therapeutic use; D006680:HLA Antigens / Q000235:genetics; D015796:HLA-B27 Antigen; D006639:Histidine / Q000097:blood; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D010648:Phenylacetates / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000175:diagnosis* / Q000188:drug therapy; D013166:Spondylitis / Q000503:physiopathology; D013167:Spondylitis, Ankylosing / Q000503:physiopathology; D013438:Sulfhydryl Compounds / Q000097:blood; D014605:Uveitis / Q000235:genetics
D000893:Anti-Inflammatory Agents; D006680:HLA Antigens; D015796:HLA-B27 Antigen; D010648:Phenylacetates; D013438:Sulfhydryl Compounds; D006052:Gold Sodium Thiomalate; D006639:Histidine; D006886:Hydroxychloroquine; D002097:C-Reactive Protein; D002216:Captopril; D002570:Ceruloplasmin; D002994:Clofibrate; D001241:Aspirin; C018431:clobuzarit